We are live on
!
Find out more
Denali Therapeutics
DNLI
DNLI
210 hedge funds and large institutions have $2.51B invested in Denali Therapeutics in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 76 increasing their positions, 69 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
10% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 69
4.02% more ownership
Funds ownership: 83.95% → 87.96% (+4%)
6% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 34
2% more call options, than puts
Call options by funds: $2.5M | Put options by funds: $2.46M
1% more capital invested
Capital invested by funds: $2.49B → $2.51B (+$25.8M)
0% more funds holding
Funds holding: 209 → 210 (+1)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
210
Holders Change
+1
Holders Change %
+0.48%
% of All Funds
3.03%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.07%
New
36
Increased
76
Reduced
69
Closed
34
Calls
$2.5M
Puts
$2.46M
Net Calls
+$40K
Net Calls Change
-$301K
Top Buyers
Top Sellers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$29M |
| 2 |
Temasek Holdings
Singapore
|
-$22.4M |
| 3 |
Morgan Stanley
New York
|
-$19.3M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$18.4M |
| 5 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
-$18M |
